Daclizumab and Alemtuzumab as Induction Agents in Adult Intestinal and Multivisceral Transplantation: Rejection and Infection Rates in 40 Recipients During the Early Postoperative Period-Reference-Cited by-同舟云学术

Daclizumab and Alemtuzumab as Induction Agents in Adult Intestinal and Multivisceral Transplantation: Rejection and Infection Rates in 40 Recipients During the Early Postoperative Period

Published:2010-01 Issue:1 Volume:42 Page:35-38
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Zanfi C.,Lauro A.,Cescon M.,Dazzi A.,Ercolani G.,Grazi G.L.,Zanello M.,Vivarelli M.,Del Gaudio M.,Ravaioli M.,Cucchetti A.,Vetrone G.,Tuci F.,Di Gioia P.,Lazzarotto T.,D'Errico A.,Bagni A.,Faenza S.,Siniscalchi A.,Pironi L.,Pinna A.D.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference6 articles.

1. Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation;Tzakis;Transplantation,2003

2. 2003 report of the Intestinal Transplant Registry: a new era has dawned;Grant;Ann Surg,2005

3. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance;Abu-Elmagd;Transplant Int,2009

4. Induction therapy for clinical intestinal transplantation: comparison of four different regimens;Pinna;Transplant Proc,2000

5. Intestinal transplantation with alemtuzumab (Campath-1H): indication for adult patients;Nishida;Transplant Proc,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in induction immunosuppression regimens for intestinal transplantation;Human Immunology;2024-05

2. Pediatric intestinal transplantation;Seminars in Pediatric Surgery;2022-06

3. Update on immunosuppressive strategies in intestinal transplantation;Current Opinion in Organ Transplantation;2022-02-03

4. Immunosuppression in liver and intestinal transplantation;Best Practice & Research Clinical Gastroenterology;2021-10

5. Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors;Mycoses;2017-04-26